These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD. Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487 [TBL] [Abstract][Full Text] [Related]
27. Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis. Chackelevicius CM; Gambaro SE; Tiribelli C; Rosso N World J Gastroenterol; 2016 Nov; 22(41):9096-9103. PubMed ID: 27895397 [TBL] [Abstract][Full Text] [Related]
28. Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma. Gomes AL; Teijeiro A; Burén S; Tummala KS; Yilmaz M; Waisman A; Theurillat JP; Perna C; Djouder N Cancer Cell; 2016 Jul; 30(1):161-175. PubMed ID: 27411590 [TBL] [Abstract][Full Text] [Related]
29. The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis. Wang T; Sun G; Wang Y; Li S; Zhao X; Zhang C; Jin H; Tian D; Liu K; Shi W; Tian Y; Zhang D FASEB J; 2019 Jul; 33(7):8490-8503. PubMed ID: 30951375 [TBL] [Abstract][Full Text] [Related]
30. [Nicotine alleviates the liver inflammation of non-alcoholic steatohepatitis induced by high-fat and high-fructose in mice]. Chen XM; Li FQ; Yan S; Wu XC; Tang CL Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):777-782. PubMed ID: 27752155 [TBL] [Abstract][Full Text] [Related]
31. Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis. Mells JE; Fu PP; Kumar P; Smith T; Karpen SJ; Anania FA J Nutr Biochem; 2015 Mar; 26(3):285-92. PubMed ID: 25577467 [TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor 3 ablation prevented high-fat diet-induced obesity and metabolic disorder. Zhang G; Li R; Li W; Yang S; Sun Q; Yin H; Wang C; Hou B; Wang H; Yu L; Chen R; Shi L; Zhang K; Liew CW; Qiang G; Sun Q; Liu C J Nutr Biochem; 2021 Sep; 95():108761. PubMed ID: 33965533 [TBL] [Abstract][Full Text] [Related]
33. Depletion of CD40 on CD11c Aarts S; Reiche M; den Toom M; Gijbels M; Beckers L; Gerdes N; Lutgens E Sci Rep; 2019 Oct; 9(1):14702. PubMed ID: 31604965 [TBL] [Abstract][Full Text] [Related]
34. Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice. Bijnen M; Josefs T; Cuijpers I; Maalsen CJ; van de Gaar J; Vroomen M; Wijnands E; Rensen SS; Greve JWM; Hofker MH; Biessen EAL; Stehouwer CDA; Schalkwijk CG; Wouters K Gut; 2018 Jul; 67(7):1317-1327. PubMed ID: 29074725 [TBL] [Abstract][Full Text] [Related]
35. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition. Krishnan A; Abdullah TS; Mounajjed T; Hartono S; McConico A; White T; LeBrasseur N; Lanza I; Nair S; Gores G; Charlton M Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G666-G680. PubMed ID: 28232454 [TBL] [Abstract][Full Text] [Related]
36. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145 [TBL] [Abstract][Full Text] [Related]
37. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis. Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624 [TBL] [Abstract][Full Text] [Related]
38. Trypanosoma cruzi infection is a potent risk factor for non-alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disorders. Onofrio LI; Arocena AR; Paroli AF; Cabalén ME; Andrada MC; Cano RC; Gea S PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003464. PubMed ID: 25668433 [TBL] [Abstract][Full Text] [Related]